Tag: Securities and Exchange Commission

The move into “America’s Favorite Small Town” strengthens the community bank’s commitment to supporting California’s food, agriculture, and small business economy

BEIJING, June 23, 2026 (GLOBE NEWSWIRE) -- Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today officially launched the all-new Li L8, with deliveries to commence within this week. The vehicle is available in Ultra and Livis trims, priced at RMB369,800 and RMB429,800, respectively. For more details on the all-new Li L8, please visit Li Auto’s official website.

CLAYMONT, Del., June 23, 2026 (GLOBE NEWSWIRE) -- Archimedes Tech SPAC Partners II Co. (Nasdaq: ATII), a publicly traded special purpose acquisition company (“ATII” or “Archimedes II”), today announced the filing with the U.S. Securities and Exchange Commission (the “SEC”), on June 22, 2026, of an amendment to the registration statement on Form S-4 (File No.: 333-295563) (as may be amended from time to time, the “Registration Statement”) previously filed in connection with the previously announced proposed business combination with Forge Nano, Inc. (“Forge Nano”). The Registration Statement includes a preliminary proxy statement/prospectus and has not yet been declared effective. The Registration Statement was filed by ATII Holdings Inc. (CIK 0002101833), ATII’s wholly-owned subsidiary (“Pubco”), and Forge Nano (CIK 0001719324) and is available free of charge at the SEC’s web site at www.sec.gov.

Order leverages Actelis’ GL800 multi-Gigabit hybrid fiber-copper solution to deliver fiber-grade connectivity into Multi Dwelling Unit buildings for Small Office/Home Office (SOHO) customers, extending Actelis’ footprint within a global telecommunications group 

Publication of MONITOR-Breast study marks latest milestone for clinical validity of Precise MRD

New system builds on Smartstack’s modular architecture, delivering industry-leading site-level density

TORONTO, ONTARIO, June 22, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“COSCIENS” or the “Company”) announced the next steps in connection with changes to the Company’s share capital (the “Share Capital Amendment”).